Vaxxinity, Inc.
NASDAQ:VAXX
Overview | Financials
Company Name | Vaxxinity, Inc. |
Symbol | VAXX |
Currency | USD |
Price | 0.001 |
Market Cap | 63,392 |
Dividend Yield | 0% |
52-week-range | 0 - 1.05 |
Industry | Biotechnology |
Sector | Healthcare |
CEO | Ms. Mei Mei Hu J.D. |
Website | https://www.vaxxinity.com |
An error occurred while fetching data.
About Vaxxinity, Inc.
Vaxxinity, Inc., a biotechnology company, focuses on developing product candidates for human use in the fields of neurology and coronaviruses in the United States. The company engages in developing UB-311 that targets toxic forms of aggregated amyloid-b in the brain to fight Alzheimer's disease (AD) that is in phase 2
Related Stocks
Financials
Numbers are in millions USD
Numbers are in millions USD